JLCVX
Price
$72.74
Change
+$0.34 (+0.47%)
Updated
Jul 2 closing price
Net Assets
6.18B
VSTSX
Price
$353.73
Change
-$0.18 (-0.05%)
Updated
Jul 2 closing price
Net Assets
2.31T
Interact to see
Advertisement

JLCVX vs VSTSX

JLCVX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
JLCVX vs. VSTSX commentary
Jul 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JLCVX is a Hold and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.31T vs. JLCVX (6.18B). VSTSX pays higher dividends than JLCVX: VSTSX (1.07) vs JLCVX (0.49). JLCVX was incepted earlier than VSTSX: JLCVX (17 years) vs VSTSX (10 years). JLCVX (0.71) is less costly to investors than VSTSX (0.01). JLCVX is a more actively managed with annual turnover of: 49.00 vs. VSTSX (3.00). JLCVX has a lower initial minimum investment than VSTSX: JLCVX (0) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 20.88 vs. JLCVX (-0.87). VSTSX return over 5 years is better than : 64.63 vs. JLCVX (-3.25).
JLCVXVSTSXJLCVX / VSTSX
Total Expense Ratio0.700.017,000%
Annual Report Gross Expense Ratio0.710.017,100%
Fund Existence17 years10 years-
Gain YTD2.23510.10922%
Front LoadN/AN/A-
Min. Initial Investment05000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets6.18B2.31T0%
Annual Yield % from dividends0.491.0745%
Returns for 1 year-0.8720.88-4%
Returns for 3 years14.8667.6322%
Returns for 5 years-3.2564.63-5%
Returns for 10 years77.68246.0832%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TBWAX22.620.34
+1.53%
Thornburg Better World International A
FRINX12.560.06
+0.48%
Fidelity Advisor Real Estate Income A
CALRX33.660.01
+0.03%
Calvert Small-Cap R6
RNWEX105.05-1.94
-1.81%
American Funds New World R4
MCYIX16.85-0.50
-2.88%
NYLI Candriam Emerging Markets Eq Cl I